ReviewFrontiers in pharmacology2018
Major Bioactive Compounds in Essential Oils Extracted From the Rhizomes of
Review in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 41 citations in OpenAlex.
- Antibacterial Potential and Phytochemical Composition in Subcritical Water Extraction of Lempoyang (Tropical life sciences research · 2025Article
- Green synthesis of silver nanoparticles usingCytotechnology · 2025Article
- Immunomodulatory Activities of Thai Herbs and the Druggability of Their Bioactive Constituents: A Comprehensive Review for Potential Phytopharmaceutical Product Development.Drug design, development and therapy · 2025Review
- Biologically Active Compounds of Malaysian Medicinal and Aromatic Plants.Progress in the chemistry of organic natural products · 2025Review
- Effect of post-harvest drying period on the chemical composition ofPhysiology and molecular biology of plants : an international journal of functional plant biology · 2024Article
- Widely Targeted Volatilomics and Metabolomics Analysis Reveal the Metabolic Composition and Diversity of Zingiberaceae Plants.Metabolites · 2023Article
- Zerumbone Disturbs the Extracellular Matrix of Fluconazole-ResistantJournal of fungi (Basel, Switzerland) · 2023Article
- Plants of the Genus Zingiber: A Review of Their Ethnomedicine, Phytochemistry and Pharmacology.Molecules (Basel, Switzerland) · 2022Review
- Target identification of anticancer natural products using a chemical proteomics approach.RSC advances · 2021Review
- Meroterpenoids FromFrontiers in chemistry · 2021Article
- Chemical Composition, Antibacterial, and Anti-Inflammatory Activities of Essential Oils from Flower, Leaf, and Stem ofBioMed research international · 2021Article
- Chemical Composition, Antibacterial, Anti-Inflammatory, and Enzyme Inhibitory Activities of Essential Oil fromMolecules (Basel, Switzerland) · 2020Article
- Formulation and Nanotechnology-Based Approaches for Solubility and Bioavailability Enhancement of Zerumbone.Medicina (Kaunas, Lithuania) · 2020Review
- Chemopreventive Potential of Caryophyllane Sesquiterpenes: An Overview of Preliminary Evidence.Cancers · 2020Review
- Phytochemical Compositions and Biological Activities of Essential Oils from the Leaves, Rhizomes and Whole Plant ofAntibiotics (Basel, Switzerland) · 2020Article
- Article
- Comparison of Chemical Composition and Bioactivities of Essential Oils from Fresh and Dry Rhizomes ofBioMed research international · 2020Article
- Potential of Zerumbone as an Anti-Cancer Agent.Molecules (Basel, Switzerland) · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.